Anti-DLL4 Reference Antibody (demcizumab) | Ubiquitin Ligase-ubiquitin-ligase.com

Product Name :
Anti-DLL4 Reference Antibody (demcizumab)

synonym :
null,

productDescription :
Anti-DLL4 Reference Antibody (demcizumab)(CHA198) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

molecularWeight :
145.5 kDa

endotoxin :
<1 EU/mg

purity :
>95%

formulation :
1×PBS, pH 6

storage :
-80℃

reactivity :

concentration :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cdk2 Antibody
VEGFA Antibody
CD19 Antibody (YA543): CD19 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to CD19. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

Author: Ubiquitin Ligase- ubiquitin-ligase

Related Posts